Issue 25
Get instant access to latest e-book

latest newsRead more...

25

Feb 2017

ANI Pharmaceuticals Acquires Inderal® XL and InnoPran XL®

ANI Pharmaceuticals Inc announced that it has acquired Inderal XL from Cranford Pharmaceuticals LLC and InnoPran XL from Holmdel Pharmaceuticals LP The acquired assets include the NDA and trademark for InnoPran XL including a license to an Orange Book listed patent and a distribution license…

25

Feb 2017

Novartis wins CHMP nod for drug combo against some lung cancers

Swiss drugmaker Novartiss drugs Tafinlar and Mekinist edged closer to approval in Europe to be used together against a type of lung cancer after a key committee on Friday published a recommendation to expand the combinations indications The European Medicine Agencys EMA Committee for Medicinal…

24

Feb 2017

Santen and twoXAR Announce Strategic Research Collaboration to Discover New Glaucoma Treatments

Santen Inc the US subsidiary of Santen Pharmaceutical Co Ltd the specialty ophthalmology company headquartered in Osaka Japan and twoXAR Inc an artificial intelligencedriven biopharmaceutical company today announced that the two companies have entered into a strategic research collaboration focused on the identification of new…

press releasesRead more...

24

Feb 2017

Acticor Biotech Has Selected Its Contract Research Organisation to Manage Clinical Study Phase I

Acticor Biotech a biotechnology company focused on the treatment of acute ischemic stroke today announced that it selected its CRO Contract Research Organization to manage its clinical study phase I…

24

Feb 2017

Fusion Pharmaceuticals Launches with a $25M USD Series A Financing to Develop Targeted Radiotherapeutics as Cancer Treatments

Fusion Pharmaceuticals a newly formed biopharmaceutical company developing targeted alphaparticle radiotherapeutics for treating cancer today announced the closing of a million Series A financing led by founding venture investor Johnson…

23

Feb 2017

Lannett Provides Further Update On Methylphenidate ER Tablets

Lannett Company Inc announced that it was notified by US Food and Drug Administration FDA late yesterday afternoon that FDA suspended indefinitely the deadline for the Company to submit materials…

EventsRead more...

27-28

Feb 2017

TOP ARTICLES

  • 2

    Parenteral Preparations

    INTRODUCTION Parenteral preparations are defined as solutions suspensionsemulsions for injection or infusion powders for injection or infusion gels for injecti..

Knowledge Bank

  • Interviews

    Datwyler Pharma Packaging

    Senior Manager Global Scientific Affairs
    Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Re..

  • Articles

    Improving Biopharma Productivity through Optimal Bioreactor Operation

    Generating global revenue of US billion biopharmaceuticals account for one fifth of pharmaceutical market The revenue grows at per cent annually which is double that of conventional pharmaceutical products The growing demand for therapeutic proteins and increasing focus from regulatory bodies have confronted the industry with challenges of ensuring affordability delivery and consistent quality…

  • Techno Trends

    New Liquid Biopsy Chip Allows to Trap Cancer Cells Easily

    Worcester Polytechnic Institute WPI researchers have developed a new chip that traps and identifies metastatic cancer cells within a tiny amount of blood drawn from a cancer patient Liquid Biopsy technique helps to capture and identify tumour cells andor DNA This technology uses a simple mechanical method which is efficient in trapping cancer cells than the micro fluidic approach used…

Editorial Section

  • Strategy

    The Future of Pharma Regulations

    The future of pharma regulations is challenging with diverse and complex regulations globally It will be challenging for industry to adapt to regulated and semiregulated markets alike while attempting to develop a harmonised strategy with evergrowing cost pressure on offpatent…

  • Research development

    Drug Development

    Drug development is a complex time consuming and expensive process involving numerous stakeholders activities and regulatory authorities Broadly it can be classified in six steps starting from identification of lead molecule till submission of reports for marketing authorisation This process…

  • Clinical Trails

    Mobile Phones Always There Always On

    With rapid growth of mobile smart phones and discovery of remote diagnostics devices there are enormous opportunities to use mobile technologies and integrated wireless devices during clinical trials to improve patients medication regimen reduce dropouts reduce site visits and improve…

  • Expert Talk

    Pushing the Limits of Temperature Control

    Todays pharmaceutical environment has become increasingly complex with more specialty products like biologics injectable and clinical trial drugs being shipped than ever The industry standard for commercial packaging is hours which is no longer always…

TOP